Urate-Lowering Drugs and Prevention of Cardiovascular Disease: The Emerging Role of Xanthine Oxidase Inhibition

Hypertension

Volumn 67, Issue 3, 2016, Pages 496-498

  Borghi, Claudio ^a   Desideri, Giovambattista ^b  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b UNIVERSITY OF L'AQUILA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOPURINOL; PROBENECID; URIC ACID; XANTHINE OXIDASE;

CARDIOVASCULAR DISEASE; CARDIOVASCULAR EFFECT; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; CONGESTIVE HEART FAILURE; ENZYME INHIBITION; HUMAN; HYPERTENSION; HYPERURICEMIA; NOTE; OXIDATIVE STRESS; PRIORITY JOURNAL; RISK REDUCTION; URIC ACID BLOOD LEVEL; BLOOD PRESSURE; FEMALE; MALE; MYOCARDIAL INFARCTION; PHYSIOLOGY; STROKE;

ALLOPURINOL; BLOOD PRESSURE; FEMALE; HUMANS; HYPERTENSION; MALE; MYOCARDIAL INFARCTION; STROKE;

EID: 84958043417     PISSN: 0194911X     EISSN: 15244563     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.115.06531     Document Type: Note

References (12)

1. Galassi FM, Borghi C. A brief history of uric acid: from gout to cardiovascular risk factor. Eur J Intern Med. 2015; 26: 373. doi: 10.1016/j. ejim.2015.04.005.
2. Borghi C, Rosei EA, Bardin T, Dawson J, Dominiczak A, Kielstein JT, Manolis AJ, Perez-Ruiz F, Mancia G. Serum uric acid and the risk of cardiovascular and renal disease. J Hypertens. 2015; 33: 1729-1741; discussion 1741. doi: 10.1097/HJH.0000000000000701.
3. Beattie CJ, Fulton RL, Higgins P, Padmanabhan S, McCallum L, Walters MR, Dominiczak AF, Touyz RM, Dawson J. Allopurinol initiation and change in blood pressure in older adults with hypertension. Hypertension. 2014; 64: 1102-1107. doi: 10.1161/HYPERTENSIONAHA.114.03953.
4. Hare JM, Mangal B, Brown J, Fisher C Jr, Freudenberger R, Colucci WS, Mann DL, Liu P, Givertz MM, Schwarz RP; OPT-CHF Investigators. Impact of oxypurinol in patients with symptomatic heart failure. Results of the OPT-CHF study. J Am Coll Cardiol. 2008; 51: 2301-2309. doi: 10.1016/j.jacc.2008.01.068.
5. Dubreuil M, Zhu Y, Zhang Y, Seeger JD, Lu N, Rho YH, Choi HK. Allopurinol initiation and all-cause mortality in the general population. Ann Rheum Dis. 2015; 74: 1368-1372. doi: 10.1136/annrheumdis-2014-205269.
6. MacIsaac RL, Salatski J, Higgins P, Walters MR, Padmanabjan S, Dominiczak AF, Touyz RM, Dawson J. Allopurinoil and cardiovascular outcomes in adultes with hypertension. Hypertension. 2016; 67: 535-540. doi: 10.1161/HYPERTENSIONAHA.115.06344.
7. Banegas JR, López-García E, Dallongeville J, Guallar E, Halcox JP, Borghi C, Massó-González EL, Jiménez FJ, Perk J, Steg PG, De Backer G, Rodríguez- Artalejo F. Achievement of treatment goals for primary prevention of cardiovascular disease in clinical practice across Europe: the EURIKA study. Eur Heart J. 2011; 32: 2143-2152. doi: 10.1093/eurheartj/ehr080.
8. Higgins P, Dawson J, Lees KR, McArthur K, Quinn TJ, Walters MR. Xanthine oxidase inhibition for the treatment of cardiovascular disease: a systematic review and meta-analysis. Cardiovasc Ther. 2012; 30: 217-226. doi: 10.1111/j.1755-5922.2011.00277.x.
9. Filippatos GS, Ahmed MI, Gladden JD, Mujib M, Aban IB, Love TE, Sanders PW, Pitt B, Anker SD, Ahmed A. Hyperuricaemia, chronic kidney disease, and outcomes in heart failure: potential mechanistic insights from epidemiological data. Eur Heart J. 2011; 32: 712-720. doi: 10.1093/eurheartj/ehq473.
10. Farquharson CA, Butler R, Hill A, Belch JJ, Struthers AD. Allopurinol improves endothelial dysfunction in chronic heart failure. Circulation. 2002; 106: 221-226.
11. Lanaspa MA, Sanchez-Lozada LG, Choi YJ, et al. Uric acid induces hepatic steatosis by generation of mitochondrial oxidative stress: potential role in fructose-dependent and -independent fatty liver. J Biol Chem. 2012; 287: 40732-40744. doi: 10.1074/jbc.M112.399899.
12. Sánchez-Lozada LG, Lanaspa MA, Cristóbal-García M, García-Arroyo F, Soto V, Cruz-Robles D, Nakagawa T, Yu MA, Kang DH, Johnson RJ. Uric acid-induced endothelial dysfunction is associated with mitochondrial alterations and decreased intracellular ATP concentrations. Nephron Exp Nephrol. 2012; 121: e71-e78. doi: 10.1159/000345509.